These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 9010920)

  • 1. Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men.
    Schirra J; Kuwert P; Wank U; Leicht P; Arnold R; Göke B; Katschinski M
    Proc Assoc Am Physicians; 1997 Jan; 109(1):84-97. PubMed ID: 9010920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans.
    Meier JJ; Gethmann A; Nauck MA; Götze O; Schmitz F; Deacon CF; Gallwitz B; Schmidt WE; Holst JJ
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1118-23. PubMed ID: 16403774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus.
    Schirra J; Leicht P; Hildebrand P; Beglinger C; Arnold R; Göke B; Katschinski M
    J Endocrinol; 1998 Jan; 156(1):177-86. PubMed ID: 9496247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric emptying and release of incretin hormones after glucose ingestion in humans.
    Schirra J; Katschinski M; Weidmann C; Schäfer T; Wank U; Arnold R; Göke B
    J Clin Invest; 1996 Jan; 97(1):92-103. PubMed ID: 8550855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal.
    Frost GS; Brynes AE; Dhillo WS; Bloom SR; McBurney MI
    Eur J Clin Nutr; 2003 Feb; 57(2):293-8. PubMed ID: 12571662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
    Schirra J; Nicolaus M; Roggel R; Katschinski M; Storr M; Woerle HJ; Göke B
    Gut; 2006 Feb; 55(2):243-51. PubMed ID: 15985560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nitric oxide on antral motility and gastric emptying in humans.
    Konturek JW; Thor P; Domschke W
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):97-102. PubMed ID: 7712314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans.
    Meier JJ; Nauck MA; Pott A; Heinze K; Goetze O; Bulut K; Schmidt WE; Gallwitz B; Holst JJ
    Gastroenterology; 2006 Jan; 130(1):44-54. PubMed ID: 16401467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
    Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR
    Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM.
    Nauck MA; Wollschläger D; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Willms B
    Diabetologia; 1996 Dec; 39(12):1546-53. PubMed ID: 8960841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clonidine and sumatriptan on postprandial gastric volume response, antral contraction waves and emptying: an MRI study.
    Kwiatek MA; Fox MR; Steingoetter A; Menne D; Pal A; Fruehauf H; Kaufman E; Forras-Kaufman Z; Brasseur JG; Goetze O; Hebbard GS; Boesiger P; Thumshirn M; Fried M; Schwizer W
    Neurogastroenterol Motil; 2009 Sep; 21(9):928-e71. PubMed ID: 19413683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of gastrointestinal hormones in postprandial reduction of bone resorption.
    Henriksen DB; Alexandersen P; Bjarnason NH; Vilsbøll T; Hartmann B; Henriksen EE; Byrjalsen I; Krarup T; Holst JJ; Christiansen C
    J Bone Miner Res; 2003 Dec; 18(12):2180-9. PubMed ID: 14672353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men.
    Pilichiewicz AN; Chaikomin R; Brennan IM; Wishart JM; Rayner CK; Jones KL; Smout AJ; Horowitz M; Feinle-Bisset C
    Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E743-53. PubMed ID: 17609258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans.
    Schirra J; Houck P; Wank U; Arnold R; Göke B; Katschinski M
    Gut; 2000 May; 46(5):622-31. PubMed ID: 10764704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of GLP-1 on gastric motility persists after vagal deafferentation in pigs.
    Nagell CF; Wettergren A; Ørskov C; Holst JJ
    Scand J Gastroenterol; 2006 Jun; 41(6):667-72. PubMed ID: 16716964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric emptying and postprandial glucose excursions in adolescents with type 1 diabetes.
    Heptulla RA; Rodriguez LM; Mason KJ; Haymond MW
    Pediatr Diabetes; 2008 Dec; 9(6):561-6. PubMed ID: 18761650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 regulates gastroduodenal motility involving cholinergic pathways.
    Schirra J; Nicolaus M; Woerle HJ; Struckmeier C; Katschinski M; Göke B
    Neurogastroenterol Motil; 2009 Jun; 21(6):609-18, e21-2. PubMed ID: 19220754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
    Meier JJ; Kemmeries G; Holst JJ; Nauck MA
    Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.